Associate Professor, Otolaryngology, University of Minnesota Medical School
Otolaryngology (ENT)
Dr. Frank G. Ondrey, MD
|
|
Give Review
Frank Ondrey works in the field of Otolaryngology (ENT). He attended Rush Medical College. He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow (FACS)" and "Fellow (FAAO-HNS)". Frank Ondrey is a published physician. He has 79 papers published. The most current publication "Do lipoxygenases modulate normal or aberrant lympho-hematopoiesis?" He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Mechanism and efficacy of sub-50 nm tenfibgen nanocapsules for Cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma.
- Not significant but important.
- Enforced expression of nuclear factor kappa B in p53 deficient keratinocytes induces cell cycle, angiogenic potential and tumorigenesis.
- The Effect of Indomethacin on Paclitaxel Sensitivity and Apoptosis in Oral Squamous Carcinoma Cells: The Role of Nuclear Factor-{kappa}B Inhibition.
- Tobacco carcinogen mediated up-regulation of AP-1 dependent pro-angiogenic cytokines in Head and neck carcinogenesis.
- Interleukin-8 production in response to tumor necrosis factor-alpha by cholesteatoma keratinocytes in cell culture.
- Conference Report: Eighth Annual AACR International Conference on Frontiers in Cancer Prevention Research.
- Inhibitor of differentiation 1 contributes to Head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pat...
- Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions.
- Expression of fibroblast growth factor binding protein in head and neck Cancer.
- Ototoxicity after combined platinum and fractionated radiation in a novel guinea pig model.
- Pilot randomized phase II study of celecoxib in oral premalignant lesions.
- Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.
- A method of producing carcinoma in upper aerodigestive tree and esophagus of the Syrian golden hamster using wounding and instillation of N-methylnitrosourea.
- Id1 induces the proliferation of cochlear sensory epithelial cells via the nuclear factor-kappaB/cyclin D1 pathway in vitro.
- Pneumococcal peptidoglycan-polysaccharides induce the expression of interleukin-8 in airway epithelial cells by way of nuclear factor-kappaB, nuclear factor interleuki...
- Sensorineural Hearing loss in Vogt-Koyanagi-Harada syndrome.
- Decreased Hearing after combined modality therapy for head and neck cancer.
- PPAR activation and decreased proliferation in oral carcinoma cells with 4-HPR.
- A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with Head and neck squamous cel...
- Induction of heat shock protein 70 inhibits NF-kappa-B in squamous cell carcinoma.
- A new immune-competent animal model of mucosally derived squamous cell carcinoma.
- Irreversible ototoxicity associated with difluoromethylornithine.
- Identification of a gene expression signature associated with recurrent Disease in squamous cell carcinoma of the head and neck.
- Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral Cancer biomarker.
- Auditory Dysfunction in Stickler syndrome.
- Prospective comparison of panoramic tomography (zonography) and helical computed tomography in the diagnosis and operative management of mandibular Fractures.
- Recommendations for Cancer prevention trials using potentially ototoxic test agents.
- Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck Cancer.
- Cisplatin and radiation sensitivity in human Head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF-kappaB.
- Inhibition of transcription factor nuclear factor-kappaB by a mutant inhibitor-kappaBalpha attenuates resistance of human Head and neck squamous cell carcinoma to TNF-...
- Contribution of conventional axial computed tomography (nonhelical), in conjunction with panoramic tomography (zonography), in evaluating mandibular Fractures.
- Asymptomatic Laryngeal malformations are common in patients with Pallister-Hall syndrome.
- Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation?
- Radiation dose to otologic structures during head and neck Cancer radiation therapy.
- Modulation of cellular proliferation and induction of apoptosis in a human lymphoma cell line after treatment with selective lipoxygenase inhibitors.
- Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human Head and neck squamous cell carcinoma cell lines that express pro-inflammatory ...
- Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human Head and neck squamous cell carcinoma inhibits survival, proinflammato...
- Expression of proinflammatory and proangiogenic cytokines in patients with head and neck Cancer.
- Do lipoxygenases modulate normal or aberrant lympho-hematopoiesis?
- Early-response cytokine expression in adult middle ear effusions.
- Histopathology of human temporal bone after cis-platinum, radiation, or both.
- Arachidonic acid metabolism: a primer for Head and neck surgeons.
- Decreased DNA synthesis in SCC-25 cells with ETYA and SC41661.
- Linkage mapping and phenotypic analysis of autosomal dominant Pallister-Hall syndrome.
- Effect of lipoxygenase inhibition on mucous glycoprotein secretion from chinchilla middle ear epithelial cells in vitro.
- Inhibition of Head and neck tumor cell growth with arachidonic acid metabolism inhibition.
- Effects of nutrition on wound healing.
- The selective 5-lipoxygenase inhibitor A63162 reduces PC3 proliferation and initiates morphologic changes consistent with secretion.
- Differentiation of U937 cells induced by 5,8,11,14-eicosatetraynoic acid, a competitive inhibitor of arachidonic acid metabolism.
- Synthesis of eicosanoids by gamma-interferon-differentiated U937 cells.
- Human PC-3 prostate cell line DNA synthesis is suppressed by eicosatetraynoic acid, an in vitro inhibitor of arachidonic acid metabolism.
- 5,8,11,14-eicosatetraynoic acid-induced differentiation of U937 cells.
- Arachidonic acid analogues: an additional class of membrane--active agents with potential antiCancer activity.
- Effect of nordihydroguaiaretic acid on cultured rat and human glioma cell proliferation.
- Inhibition of U937 eicosanoid and DNA synthesis by 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonic acid metabolism and its partial reversal by leukotriene...
- Tumor cell mitochondrial matrix/cristae complexes as potential sites for antiCancer therapy with polyunsaturated fatty acid analogues.
- ETYA, a pleotropic membrane-active arachidonic acid analogue affects multiple signal transduction pathways in cultured transformed mammalian cells.
- Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung Cancer growth inhibition.
- NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma.
- Pseudomonas aeruginosa lipopolysaccharide induction of keratinocyte proliferation, NF-kappa B, and cyclin D1 is inhibited by indomethacin.
- A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients.
- Characterization of a temperature-sensitive mouse middle ear epithelial cell line.
- The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus.
- NF-Kappa-B downregulation strategies in head and neck Cancer treatment.
- Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone.
- Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus.
- Efficacy of an osmotic pump delivered, GM-CSF-based tumor vaccine in the treatment of upper aerodigestive squamous cell carcinoma in rats.
- Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma.
- Presence of otitis media with effusion and its risk factors affect serum cytokine profile in children.
- TNF-alpha drives matrix metalloproteinase-9 in squamous oral carcinogenesis.
- The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.
- Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention.
- Cigarette smoke condensate induces nuclear factor kappa-b activity and proangiogenic growth factors in aerodigestive cells.
- A metaproteomic analysis of the human salivary microbiota by three-dimensional peptide fractionation and tandem mass spectrometry.
- Exons 19 and 21 of epidermal growth factor receptor are highly conserved in squamous cell Cancer of the head and neck.
- The role of inhibitor of DNA-binding (Id1) in hyperproliferation of keratinocytes: the pathological basis for middle ear cholesteatoma from Chronic otitis media.
- Functional activation of PPARγ in human upper aerodigestive Cancer cell lines.
Schools
Rush Medical College Of Rush University
Hennepin County Med Center
University Of Minnesota
Procedures Preformed
- Ablation or Excision of Nasal Turbinates
- Antrostomy and Antrotomy (Sinus Surgery)
- Continuous Positive Airway Pressure (CPAP)
- Diagnostic Nasal and-or Sinus Endoscopy
- View All
Conditions Treated
- Acute Laryngitis
- Acute Tonsillitis
- Allergic Rhinitis
- Bell's Palsy
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Otolaryngology (ENT)
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
- Fellow (FAAO-HNS)
Education
-
University of Minnesota -
Hennepin County Medical Center -
Rush Medical College
Hospital
-
University of Minnesota Medical Center, Fairview -
Hennepin County Medical Center -
Regions Hospital
Drug Facts
| NPI NUMBER | 1508941428 | |
| NPPES Provider LastName | ONDREY | |
| NPPES Provider FirstName | FRANK | |
| NPPES Provider ZIPCode | 554550356 | |
| NPPES Provider State | MN | |
| Specialty Description | Otolaryngology | |
| Total Claim Count | 445.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 64.0 | |
| Percent Opioid Claims | 14.38 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1508941428 |
| Last Name Of The Provider | ONDREY |
| First Name Of The Provider | FRANK |
| View All |
Similar Doctors
|
|
Dr. Christopher W. Hilton, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Rex S. Haberman II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seth C. Janus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David D. Hamlar Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leighton G. Siegel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael B. Johnson, MD |
|
|
Dr. Manuela Fina, MD
This Doctor is OpenDoctor Recommended.
|